Trifluoroacetic acid → 3-(7-Isopropyl-4-oxo-4,5-dihydro-3H-benzo[b][1,4]diazepin-2-yl)-benzonitrile
반응식
C(OC(=O)[NH:7][C:8]1[CH:13]=[CH:12][C:11]([CH:14]([CH3:16])[CH3:15])=[CH:10][C:9]=1[NH:17][C:18](=[O:30])[CH2:19][C:20]([C:22]1[CH:27]=[CH:26][CH:25]=[C:24]([C:28]#[N:29])[CH:23]=1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH:14]([C:11]1[CH:12]=[CH:13][C:8]2[N:7]=[C:20]([C:22]3[CH:23]=[C:24]([CH:25]=[CH:26][CH:27]=3)[C:28]#[N:29])[CH2:19][C:18](=[O:30])[NH:17][C:9]=2[CH:10]=1)([CH3:16])[CH3:15]참가 물질
4
실험 절차
Prepared from {2-[3-(3-cyano-phenyl)-3-oxo-propionylamino]-4-isopropyl-phenyl}-carbamic acid tert.-butyl ester (Example K86) by treatment with TFA in CH2Cl2 according to the general procedure M. Obtained as an off-white solid (25 mg).
출처 및 근거
- ORD 기록
- ord-5bd931ac5fb54be5bf784670210f2ac0
- 출처 데이터셋
- uspto-grants-2005_11
- 특허 번호
- US06960578B2
반응 노트
불러오는 중…